Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Retatrutide (60mg Vial) Dosage Protocol Retatrutide is a first-in-class triple agonist it engages the GLP-1, GIP, and glucagon receptors all at once and has been studied for substantial weight loss and broad metabolic improvement in obesity and type 2 diabetes
The post-discontinuation phase remains the least investigated, although extension studies consistently show that weight regain occurs rapidly, with patients regaining up to two-thirds of the lost weight within one year after withdrawal (22)
Multiply by 100 for syringe units
GLP-1s may act as a vaccine for addiction, potentially leading to a significant public health impact, even without intentional use for addiction treatment
US$ 28.54
US$ 22.08
US$ 21.51
